• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

构建并验证了一个基于 Lasso-Logistic 回归的动态列线图,用于预测入院时严重发热伴血小板减少综合征患者的严重程度。

Construction and validation of a dynamic nomogram using Lasso-logistic regression for predicting the severity of severe fever with thrombocytopenia syndrome patients at admission.

机构信息

Department of Pharmacy, Nanjing Drum Tower Hospital, School of Pharmacy, Nanjing Medical University, Nanjing, Jiangsu, China.

School of Pharmacy, Nanjing Medical University, Nanjing, Jiangsu, China.

出版信息

BMC Infect Dis. 2024 Sep 18;24(1):996. doi: 10.1186/s12879-024-09867-z.

DOI:10.1186/s12879-024-09867-z
PMID:39294596
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11409798/
Abstract

BACKGROUND

Severe fever with thrombocytopenia syndrome (SFTS) is a highly fatal infectious disease caused by the SFTS virus (SFTSV), posing a significant public health threat. This study aimed to construct a dynamic model for the early identification of SFTS patients at high risk of disease progression.

METHODS

All eligible patients enrolled between April 2014 and July 2023 were divided into training and validation sets. Thirty-four clinical variables in the training set underwent analysis using least absolute shrinkage and selection operator (LASSO) logistic regression. Selected variables were then input into the multivariate logistic regression model to construct a dynamic nomogram. The model's performance was assessed using the area under the receiver operating characteristic curve (AUC-ROC), concordance index (C-index), calibration curve, and decision curve analysis (DCA) in both training and validation sets. Kaplan-Meier survival analysis was utilized to evaluate prognostic performance.

RESULTS

299 SFTS patients entered the final investigation, with 208 patients in the training set and 90 patients in the validation set. LASSO and the multivariate logistic regression identified six significant prediction factors: age (OR, 1.060; 95% CI, 1.017-1.109; P = 0.007), CREA (OR, 1.017; 95% CI, 1.003-1.031; P = 0.019), PT (OR, 1.765; 95% CI, 1.175-2.752; P = 0.008), D-dimer (OR, 1.039; 95% CI, 1.005-1.078; P = 0.032), nervous system symptoms (OR, 8.244; 95% CI, 3.035-26.858; P < 0.001) and hemorrhage symptoms (OR, 3.414; 95% CI, 1.096-10.974; P = 0.035). The AUC-ROC, C-index, calibration plots, and DCA demonstrated the robust performance of the nomogram in predicting severity at admission, and Kaplan-Meier survival analysis indicated its utility in predicting 28-day mortality among SFTS patients. The dynamic nomogram is accessible at https://sfts.shinyapps.io/SFTS_severity_nomogram/ .

CONCLUSION

This study provided a practical and readily applicable tool for the early identification of high-risk SFTS patients, enabling the timely initiation of intensified treatments and protocol adjustments to mitigate disease progression.

摘要

背景

严重发热伴血小板减少综合征(SFTS)是一种由 SFTS 病毒(SFTSV)引起的高致命性传染病,对公共卫生构成重大威胁。本研究旨在构建一个用于早期识别 SFTS 患者疾病进展高危风险的动态模型。

方法

将 2014 年 4 月至 2023 年 7 月期间纳入的所有合格患者分为训练集和验证集。在训练集中,使用最小绝对收缩和选择算子(LASSO)逻辑回归分析 34 项临床变量。选择的变量随后被输入多变量逻辑回归模型中,以构建动态列线图。使用受试者工作特征曲线(ROC)下面积(AUC-ROC)、一致性指数(C-index)、校准曲线和决策曲线分析(DCA)在训练集和验证集中评估模型性能。Kaplan-Meier 生存分析用于评估预后性能。

结果

共有 299 例 SFTS 患者进入最终研究,其中 208 例患者进入训练集,90 例患者进入验证集。LASSO 和多变量逻辑回归确定了 6 个有意义的预测因素:年龄(OR,1.060;95%CI,1.017-1.109;P=0.007)、CREA(OR,1.017;95%CI,1.003-1.031;P=0.019)、PT(OR,1.765;95%CI,1.175-2.752;P=0.008)、D-二聚体(OR,1.039;95%CI,1.005-1.078;P=0.032)、神经系统症状(OR,8.244;95%CI,3.035-26.858;P<0.001)和出血症状(OR,3.414;95%CI,1.096-10.974;P=0.035)。AUC-ROC、C-index、校准图和 DCA 表明,列线图在预测入院时严重程度方面具有稳健的性能,Kaplan-Meier 生存分析表明,它可用于预测 SFTS 患者 28 天死亡率。动态列线图可在 https://sfts.shinyapps.io/SFTS_severity_nomogram/ 上获得。

结论

本研究提供了一种实用且易于应用的工具,用于早期识别 SFTS 高危患者,从而能够及时开始强化治疗和调整方案以减轻疾病进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b3e/11409798/6569ccee0588/12879_2024_9867_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b3e/11409798/d0e246217b86/12879_2024_9867_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b3e/11409798/6dc6f5b433d1/12879_2024_9867_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b3e/11409798/cbb5c88809a9/12879_2024_9867_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b3e/11409798/50cd0afb4ebb/12879_2024_9867_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b3e/11409798/badf0f34f956/12879_2024_9867_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b3e/11409798/56383318fc3e/12879_2024_9867_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b3e/11409798/6569ccee0588/12879_2024_9867_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b3e/11409798/d0e246217b86/12879_2024_9867_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b3e/11409798/6dc6f5b433d1/12879_2024_9867_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b3e/11409798/cbb5c88809a9/12879_2024_9867_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b3e/11409798/50cd0afb4ebb/12879_2024_9867_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b3e/11409798/badf0f34f956/12879_2024_9867_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b3e/11409798/56383318fc3e/12879_2024_9867_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b3e/11409798/6569ccee0588/12879_2024_9867_Fig2_HTML.jpg

相似文献

1
Construction and validation of a dynamic nomogram using Lasso-logistic regression for predicting the severity of severe fever with thrombocytopenia syndrome patients at admission.构建并验证了一个基于 Lasso-Logistic 回归的动态列线图,用于预测入院时严重发热伴血小板减少综合征患者的严重程度。
BMC Infect Dis. 2024 Sep 18;24(1):996. doi: 10.1186/s12879-024-09867-z.
2
A nomogram including admission serum glycated albumin/albumin ratio to predict mortality in patients with severe fever with thrombocytopenia syndrome.包含入院时糖化血清白蛋白/白蛋白比值的列线图预测重症发热伴血小板减少综合征患者的死亡率。
BMC Infect Dis. 2024 Aug 23;24(1):858. doi: 10.1186/s12879-024-09752-9.
3
Establishment and validation of a clinical risk scoring model to predict fatal risk in SFTS hospitalized patients.建立并验证一个临床风险评分模型,以预测发热伴血小板减少综合征住院患者的死亡风险。
BMC Infect Dis. 2024 Sep 13;24(1):975. doi: 10.1186/s12879-024-09898-6.
4
High C-reactive protein to lymphocyte ratio predicts mortality outcomes of patients with severe fever with thrombocytopenia syndrome: A multicenter study in China.高C反应蛋白与淋巴细胞比值可预测发热伴血小板减少综合征患者的死亡结局:一项中国多中心研究
J Med Virol. 2023 Feb;95(2):e28546. doi: 10.1002/jmv.28546.
5
A nomogram and heat map based on LASSO-Cox regression for predicting the risk of early-stage severe fever with thrombocytopenia syndrome patients developing into critical illness at 7-day and 14-day.基于 LASSO-Cox 回归的列线图和热图预测早期重症发热伴血小板减少综合征患者在 7 天和 14 天发展为危重症的风险。
J Med Virol. 2024 Sep;96(9):e29921. doi: 10.1002/jmv.29921.
6
Development and validation of the PLNA score to predict cytokine storm in acute-phase SFTS patients: A single-center cohort study.PLNA 评分预测急性期发热伴血小板减少综合征患者细胞因子风暴的开发和验证:一项单中心队列研究。
Int Immunopharmacol. 2024 Jul 30;136:112288. doi: 10.1016/j.intimp.2024.112288. Epub 2024 May 31.
7
Construction and evaluation of a mortality prediction model for patients with acute kidney injury undergoing continuous renal replacement therapy based on machine learning algorithms.基于机器学习算法的行连续性肾脏替代治疗的急性肾损伤患者死亡率预测模型的构建与评估。
Ann Med. 2024 Dec;56(1):2388709. doi: 10.1080/07853890.2024.2388709. Epub 2024 Aug 19.
8
[Analysis of 28 day-mortality risk factors in sepsis patients and construction and validation of predictive model].[脓毒症患者28天死亡风险因素分析及预测模型的构建与验证]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2024 May;36(5):478-484. doi: 10.3760/cma.j.cn121430-20231109-00961.
9
[Development and validation of a nomogram for predicting 3-month mortality risk in patients with sepsis-associated acute kidney injury].[用于预测脓毒症相关性急性肾损伤患者3个月死亡风险的列线图的开发与验证]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2024 May;36(5):465-470. doi: 10.3760/cma.j.cn121430-20231218-01091.
10
Difference in hematocrit and plasma albumin levels as an early biomarker of severity and prognosis in patients with severe fever and thrombocytopenia syndrome.血细胞比容和血浆白蛋白水平的差异作为严重发热伴血小板减少综合征患者严重程度和预后的早期生物标志物。
J Med Virol. 2024 Oct;96(10):e29941. doi: 10.1002/jmv.29941.

引用本文的文献

1
Time-Varying Effects of Glucocorticoid Treatment in Critically III Patients with Severe Fever with Thrombocytopenia Syndrome: An Inverse Probability of Treatment Weighting Analysis.糖皮质激素治疗对重症发热伴血小板减少综合征重症患者的时变效应:一项治疗权重逆概率分析
J Inflamm Res. 2025 Apr 18;18:5311-5327. doi: 10.2147/JIR.S505421. eCollection 2025.

本文引用的文献

1
High CRP/PNI levels predict an unfavorable prognosis in severe fever with thrombocytopenia syndrome: A propensity score matching study.高CRP/PNI水平预示着发热伴血小板减少综合征患者预后不良:一项倾向评分匹配研究
Immun Inflamm Dis. 2024 Feb;12(2):e1184. doi: 10.1002/iid3.1184.
2
Novel nomograms to predict risk and prognosis in hospitalized patients with severe fever with thrombocytopenia syndrome.预测发热伴血小板减少综合征住院患者风险和预后的新型列线图
Front Med (Lausanne). 2023 Dec 1;10:1321490. doi: 10.3389/fmed.2023.1321490. eCollection 2023.
3
Development and validation of a novel nomogram to predict postoperative pancreatic fistula after pancreatoduodenectomy using lasso-logistic regression: an international multi-institutional observational study.
基于lasso-logistic 回归建立并验证一种预测胰十二指肠切除术后胰瘘的新型列线图:一项国际多中心观察性研究。
Int J Surg. 2023 Dec 1;109(12):4027-4040. doi: 10.1097/JS9.0000000000000695.
4
Corticosteroid Therapy for Patients With Severe Fever With Thrombocytopenia Syndrome: A Nationwide Propensity Score-Matched Study in Japan.严重发热伴血小板减少综合征患者的皮质类固醇治疗:日本一项全国性倾向评分匹配研究
Open Forum Infect Dis. 2023 Aug 1;10(8):ofad418. doi: 10.1093/ofid/ofad418. eCollection 2023 Aug.
5
Severe fever with thrombocytopenia syndrome virus induces platelet activation and apoptosis via a reactive oxygen species-dependent pathway.严重发热伴血小板减少综合征病毒通过活性氧依赖途径诱导血小板活化和凋亡。
Redox Biol. 2023 Sep;65:102837. doi: 10.1016/j.redox.2023.102837. Epub 2023 Aug 1.
6
A High Viral Load in Urine Correlates With Acute Kidney Injury and Poor Outcomes in Hospitalized Patients With Severe Fever With Thrombocytopenia Syndrome: A Noninvasive and Convenient Prognostic Marker.尿液中高病毒载量与严重发热伴血小板减少综合征住院患者的急性肾损伤及不良预后相关:一种非侵入性且便捷的预后标志物。
Open Forum Infect Dis. 2023 Feb 18;10(4):ofad085. doi: 10.1093/ofid/ofad085. eCollection 2023 Apr.
7
Effect of intravenous immunoglobulin therapy on the prognosis of patients with severe fever with thrombocytopenia syndrome and neurological complications.静脉注射免疫球蛋白治疗对伴有神经并发症的重型发热伴血小板减少综合征患者预后的影响。
Front Immunol. 2023 Mar 22;14:1118039. doi: 10.3389/fimmu.2023.1118039. eCollection 2023.
8
Pulmonary infection in patients with severe fever with thrombocytopenia syndrome: A multicentre observational study.发热伴血小板减少综合征患者的肺部感染:一项多中心观察性研究。
J Med Virol. 2023 Apr;95(4):e28712. doi: 10.1002/jmv.28712.
9
Clinical efficacy of low-dose glucocorticoid therapy for critically ill patients with severe fever with thrombocytopenia syndrome: A retrospective cohort study.小剂量糖皮质激素治疗重症发热伴血小板减少综合征患者的临床疗效:一项回顾性队列研究
Int J Infect Dis. 2023 May;130:153-160. doi: 10.1016/j.ijid.2023.03.015. Epub 2023 Mar 13.
10
A new model for predicting the outcome and effectiveness of drug therapy in patients with severe fever with thrombocytopenia syndrome: A multicenter Chinese study.一种预测重症发热伴血小板减少综合征患者药物治疗效果和结局的新模型:一项多中心中国研究。
PLoS Negl Trop Dis. 2023 Mar 6;17(3):e0011158. doi: 10.1371/journal.pntd.0011158. eCollection 2023 Mar.